Promoting global vaccine equity while protecting innovation

America’s biopharmaceutical companies have successfully researched, developed and distributed billions of doses of multiple vaccines and therapeutics to halt the spread of COVID-19. The availability of COVID-19 vaccines has shifted the trajectory of the pandemic and is undoubtedly saving lives. Further, the approval of the first ever mRNA vaccines has the potential to usher in an era of groundbreaking mRNA applications beyond COVID-19.

Read the source article at The Catalyst
2021-07-15 13:49:13